Trials / Completed
CompletedNCT05471284
Recruitment Messages for Current Smokers Recently Diagnosed With Cancer
A Multimethod Evaluation of Tobacco Treatment Trial Recruitment Messages for Current Smokers Recently Diagnosed With Cancer: Pilot Factorial Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 99 (actual)
- Sponsor
- University of Oklahoma · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study was to conduct a pilot factorial randomized trial to identify the message frames that are most effective in promoting participation in a tobacco treatment trial for current smokers recently diagnosed with cancer. To do so, we used a multimethod approach to evaluate 3 different message frames across evaluation, effectiveness, and outcome measures. We combine findings from a message design experiment with textual analytic software to provide a holistic understanding of how message frames may or may not differentially affect tobacco treatment trial participation within the context of a cancer diagnosis.
Detailed description
Background: A cancer diagnosis can catalyze motivation to quit smoking. Tobacco treatment trials offer cessation resources but have low accrual rates. Digital outreach may improve accrual, but knowledge of how best to recruit smokers with recent diagnoses is limited. Objective: This study aims to identify the message frames that were most effective in promoting intent to talk to a physician about participating in a tobacco treatment trial for smokers recently diagnosed with cancer. Methods: From February to April 2019, current smokers diagnosed within the past 24 months were recruited from a national web-based panel for a multimethod pilot randomized trial (N=99). Participants were randomized to a 2×3 plus control factorial design that tested 3 unique message frames: proximal versus distal threats of smoking, costs of continued smoking versus benefits of quitting, and gains of participating versus losses of not participating in a tobacco treatment trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Proximal | The first factor tested framing of the near, proximal threat of continued smoking. |
| BEHAVIORAL | Distal | The first factor tested framing of the long-term, distal threat of continued smoking. |
| BEHAVIORAL | Cost | Cost framework measures the response efficacy to quitting smoking by displaying costs of continued smoking. |
| BEHAVIORAL | Benefit | Benefit framework measures the response efficacy to quitting smoking by displaying benefits of quitting. |
| BEHAVIORAL | Loss | The third factor tested framing of the response efficacy of participating in a cessation study by utilizing loss of not participating in a smoking cessation. |
| BEHAVIORAL | Gain | The third factor tested framing of the response efficacy of participating in a cessation study by utilizing gain of participating in a smoking cessation. |
| BEHAVIORAL | Control | Does not include any of the three message factors. |
Timeline
- Start date
- 2019-02-11
- Primary completion
- 2019-04-01
- Completion
- 2019-04-02
- First posted
- 2022-07-22
- Last updated
- 2022-07-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05471284. Inclusion in this directory is not an endorsement.